Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: A comparison of patient self-injection with homecare injection

Archives of Internal Medicine

Volumn 158, Issue 16, 1998, Pages 1809-1812

  Wells, Philip S ^a,c,d   Kovacs, Michael J ^b   Bormanis, Janis ^a   Forgie, Melissa A ^a   Goudie, Donna ^a   Morrow, Bev ^b   Kovacs, Judy ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c HEART AND STROKE FOUNDATION OF CANADA   (Canada)

^d NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; ARTICLE; COST CONTROL; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; HEALTH CARE QUALITY; HUMAN; LEG PHLEBOGRAPHY; LUNG EMBOLISM; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PATIENT EDUCATION; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTICOAGULANTS; ELIGIBILITY DETERMINATION; FEASIBILITY STUDIES; FEMALE; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HOME CARE SERVICES, HOSPITAL-BASED; HUMANS; INJECTIONS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RECURRENCE; SELF ADMINISTRATION; SURVIVAL ANALYSIS; THROMBOPHLEBITIS; TREATMENT OUTCOME;

EID: 0032517087     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.16.1809     Document Type: Article

References (12)

1. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med. 1991;151:933-938.
2. Hermann RE, Davis JH, Holden WD. Pulmonary embolism: a clinical and pathologic study with emphasis on the effect of prophylactic therapy with anticoagulants. Am J Surg. 1961;102:19-28.
3. Koopman MMW, Prandoni P, Piovella F, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low molecular weight heparin administered at home. N Engl J Med. 1996;334:682-687.
4. Levine M, Gent M, Hirsh J, et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. N Engl J Med. 1996;334:677-681.
5. Forgie MA, Wells PS, Graham I, Anderson DR. Survey of physicians' attitudes towards outpatient treatment of deep-vein thrombosis with low molecular weight heparin. Clin Invest Med. 1996;19(suppl):31.
6. Shegda LM, McCorkle R. Continuing care in the community. J Pain Symptom Manage. 1990;5:279-286.
7. Anderson DR, Levine M, Gent M, Hirsh J. Validation of a new criteria for the evaluation of bleeding during antithrombotic therapy. Thromb Haemost. 1993;69 (suppl):650.
8. Hull RD, Hirsh J, Carter CJ, et al. Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med. 1983;98:891-899.
9. Wells PS, Ginsberg JS. Deep-vein thrombosis and pulmonary embolism: choosing the right diagnostic tests for patients at risk. Geriatrics. 1995;50:29-36.
10. The Columbus Investigators. Low molecular weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med. 1997;335:657-662.
11. Lindmarker P, Holmstrom H. Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis: a feasibility and health economic study in an outpatient setting. J Intern Med. 1996;240:395-401.
12. Flessinger JN, Lopez-Fernandez M, Gatterer E, et al. Once daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep venous thrombosis. Thromb Haemost. 1996;76:195-199.